BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14559161)

  • 21. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene.
    Nishikawa Y; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Vaccine; 2001 Feb; 19(13-14):1710-6. PubMed ID: 11166895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neospora caninum: role for immune cytokines in host immunity.
    Khan IA; Schwartzman JD; Fonseka S; Kasper LH
    Exp Parasitol; 1997 Jan; 85(1):24-34. PubMed ID: 9024199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neospora caninum tachyzoite- and antigen-stimulated cytokine production by bone marrow-derived dendritic cells and spleen cells of naive BALB/c mice.
    Feng X; Zhang N; Tuo W
    J Parasitol; 2010 Aug; 96(4):717-23. PubMed ID: 20738198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
    Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
    Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice.
    Rojo-Montejo S; Collantes-Fernández E; Rodríguez-Marcos S; Pérez-Zaballos F; López-Pérez I; Prenafeta A; Ortega-Mora LM
    Parasitology; 2011 Sep; 138(11):1372-83. PubMed ID: 21810300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP3 Inflammasome Participates in Host Response to
    Wang X; Gong P; Zhang X; Li S; Lu X; Zhao C; Yu Q; Wei Z; Yang Y; Liu Q; Yang Z; Li J; Zhang X
    Front Immunol; 2018; 9():1791. PubMed ID: 30105037
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunization with Neospora caninum profilin induces limited protection and a regulatory T-cell response in mice.
    Mansilla FC; Quintana ME; Langellotti C; Wilda M; Martinez A; Fonzo A; Moore DP; Cardoso N; Capozzo AV
    Exp Parasitol; 2016 Jan; 160():1-10. PubMed ID: 26551412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neospora caninum Dense Granule Protein 7 Regulates the Pathogenesis of Neosporosis by Modulating Host Immune Response.
    Nishikawa Y; Shimoda N; Fereig RM; Moritaka T; Umeda K; Nishimura M; Ihara F; Kobayashi K; Himori Y; Suzuki Y; Furuoka H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006392
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production.
    Tuo W; Fetterer R; Jenkins M; Dubey JP
    Infect Immun; 2005 Aug; 73(8):5093-100. PubMed ID: 16041025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROS-mediated NLRP3 inflammasome activation participates in the response against Neospora caninum infection.
    Li L; Wang XC; Gong PT; Zhang N; Zhang X; Li S; Li X; Liu SX; Zhang XX; Li W; Li JH; Zhang XC
    Parasit Vectors; 2020 Sep; 13(1):449. PubMed ID: 32891167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
    Pinheiro AF; Roloff BC; da Silveira Moreira A; Berne MEA; Silva RA; Leite FPL
    Vaccine; 2018 Feb; 36(9):1154-1159. PubMed ID: 29395519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
    Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the chemokine receptor CCR5-dependent host defense system in Neospora caninum infections.
    Abe C; Tanaka S; Nishimura M; Ihara F; Xuan X; Nishikawa Y
    Parasit Vectors; 2015 Jan; 8():5. PubMed ID: 25558986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neospora GRA6 possesses immune-stimulating activity and confers efficient protection against Neospora caninum infection in mice.
    Fereig RM; Shimoda N; Abdelbaky HH; Kuroda Y; Nishikawa Y
    Vet Parasitol; 2019 Mar; 267():61-68. PubMed ID: 30878088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice.
    Zhang H; Nishikawa Y; Yamagishi J; Zhou J; Ikehara Y; Kojima N; Yokoyama N; Xuan X
    Exp Parasitol; 2010 Jun; 125(2):130-6. PubMed ID: 20097198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of recombinant Neospora caninum antigens purified from silkworm larvae for the protection of N. caninum infection in mice.
    Yoshimoto M; Otsuki T; Itagaki K; Kato T; Kohsaka T; Matsumoto Y; Ike K; Park EY
    J Biosci Bioeng; 2015 Dec; 120(6):715-9. PubMed ID: 25935502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunisation of mice against neosporosis.
    Lundén A; Wright S; Allen JE; Buxton D
    Int J Parasitol; 2002 Jun; 32(7):867-76. PubMed ID: 12062558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a DNA vaccine expressing the Neospora caninum surface protein NcSRS2 in mice.
    Zhao Z; Ding J; Liu Q; Wang M; Yu J; Zhang W
    Acta Vet Hung; 2009 Mar; 57(1):51-62. PubMed ID: 19457773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice.
    Aguado-Martínez A; Alvarez-García G; Fernández-García A; Risco-Castillo V; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2009 Dec; 27(52):7331-8. PubMed ID: 19782735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.